Company news: Amylin, Eli Lilly, Alkermes, Gilead and J&J
Amylin, Eli Lilly and Alkermes said the FDA accepted their Bydureon resubmission and awarded a six-month review, extending the PDUFA ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.